Urogenital Flashcards

(73 cards)

1
Q

Human glutathione S-transferase variants associated with increased risk for TCC? What about dogs? (JVIM 2019, Luethcke)

A

Human: GST theta, mu and pi, particularly null variant in GSTT1 Dogs - no correlation in 3 GST theta variants in Scotties or other dogs with TCC compared to controls (Scotties actually low)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Environmental risk for dogs with TCC (Luethcke, JVIM 2019

A

Household insecticide use, living farther away from farms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rate of clinical improvement for dogs undergoing balloon dilation for obstruction for TCC? Average duration of improvement? (Kim JAVMA 2019)

A

9/12 dogs (75%), duration median 84 days 3 dogs with recurrent obstruction had 2nd procedure which lasted 41-70d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dogs that had recurrent obstruction after urethral balloon dilation for TCC had what in common? (Kim JAVMA 2019)

A

All males, 2/3 = prostate the problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the main ultrasound differences between feline and canine TCC on ultrasound (Hamlin VRU 2019)

A

Feline more likely to be mid-body or apex vs. canine usually trigonal

Feline less likely to have urethral extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the most common appearance for feline TCC on ultrasound (Hamlin VRU 2019)

A

singular, broad-based mass within the mid-body or apex of the urinary bladder w/o urethral extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What % of invasive urothelial carcinoma is high grade?

A

70% (29% int, 1% low)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FOr dogs with iUC, what is the % met rate at dx?

A

nodal 16%, distant 14%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are known risk factors for bladder cancer?

A

exposure to older generation flea control products

lawn chemicals

obesity

female gender

breed

+/- CTX exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The BRAF mutation has been found in more than ____% of canine iUC

A

80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What IHC can be used to determine urothelial origin (i.e. for bladder tumors)

A

uroplakin III and possibly GATA-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other than Scotties, what other breeds are at an increased risk of iUC?

A

eskimo dogs, shelties, westies, keeshonds, samoyed, beagle, dalmatian (in order of descending OR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When is surgery indicated for iUC?

A
  1. obtain tissue for a definitive diagnosis
  2. eradicate lesion amenable to wide excision (tumors away from trigone)
  3. relieve urinary tract obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What was the overall PFI and MST for dogs treated with partial cystectomy + COX inhibitors? Which group did better?

A

37 dogs - all gross tumor removed in 92% of dogs

overall PFI 235d (7.8mo), MST 348d (11.6mo)

22 dogs treated with surgery + daily piroxicam MST = 722d (24mo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the range in MST after urethral stenting for iUC or prostatic carcinoma?

A

MST 20-78d (range 2-536d)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the rate of incontinence reported after urethral stent placement?

A

25-39%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

iUC are considered sensitive to RT - what generally is their alpha/beta ratio like

A

usually considered low - suggests higher doses and less fractionation would be better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What were the late complications of IMRT for iUC?

A

urethral stricture (9%), ureteral stricutre (5%), rectal stricture (5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Doses of _____ of chlorambucil in dogs (for treatement of a variety of tumor types) was associated with more GI and bone marrow tox but no improvement in antitumor effects.

A

4mg/m2/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Overall, COX inhibitors induce a remission (mostly PRs) in ____% of dogs with iUC and SD in up to _____%

A

PR 15-20%

SD 55%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

If you suspect a dog with iUC has worsening clinical signs secondary to a UTI, while waiting for culture, what should your abx drug choice be like?

A

Treated for E. coli or Staph spp (most common in non-tumor and tumor dogs)

clavamox or TMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What factors are associated with a mroe advanced TNM stage for canine iUC at diagnosis?

A

yonger age (associated with increased risk of nodal mets)

prostate involvement (increased risk of distant mets)

higher T stage (increased risk of nodal and distant mets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the most frequently diagnosed feline urinary bladder tumors?

A

iUC (TCC)

mesenchymal

lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What was the MST of 111 cats with iUC treated with meloxicam?

A

311 d (10.4mo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
**What was the MST for dogs with prostatic carcinoma treated with NSAIDs + chemo vs. NSAIDs alone? (Ravicini VCO 2018)**
**NSAIDs + Chemo = 106d** **chemo alone 51d**
26
**What was associated with a significantly shorter MST for dogs with prostatic carcinoma? (Ravicini VCO 2018)**
**Intact dogs** **Mets**
27
What % of canine prostatic carcinoma expressed cox-1 and cox-2? (Sorenmo VCO 2004)
Cox-1: 94.1% cox-2: 88.2%
28
What was the PPV and NPV for mineralization of the prostate in neutered dogs for predicting prostatic carcinoma? (Bradbury VRU 2009)
PPV 100% NPV 50% (sensitivity 84%, specificity 100%)
29
What was the PPV and NPV for prostatic mineralization predicting prostatic carcinoma in in tact male dogs? (Bradbury VRU 2009)
PPV 22%, NPV 96% other things that caused it: BPH, prostatitis, paraprostatic cysts
30
What are the patterns of prostatic carcinoma in dogs?
1. papillary 2. cribriform 3. solid 4. small acinar/ductal 5. signet ring 6. mucinous also preneoplastic: high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic inflammatory atrophy (PIA)
31
Expression of _____ changed from membranous to cytoplasmic in dogs with prostatic carcioma and was sig higher in cancer/mets vs. BPH. (Della Salda VCO 2019)
Nectin 4 (e-cadherin based adherens junction protein) also looked at p63 - cancer had decreased nuclear p63 (transcription factor
32
Similar to humans, what pathways are likely drivers for prostatic carcinoma in dogs? (Kobayashi Res Vet Sci 2018)
B-catenin, E-cadherin in WNT pathway, Caveolin-1
33
**What were the features of nuclei from neoplastic prostates vs. normal or hyperplastic? Combining this with what else helped to more precisely grade canine prostatic ca(Donato Res Vet Sci 2017)**
**Larger with greater nuclear size and shape** **combined with Gleason score**
34
What were the IHC features of prostatic intrapeithelial neoplasia (PIN) in dogs?
increased # of basal epithelial cells elevated expression of PCNA heterogenous expression of androgen receptor
35
Similar to people, overexpression of ____ and donregulation of ____ may be important steps in carcinogenesis of canine prostatic carcinoma (Lin J Comp Path 2016)
overexpression of stat3 (82% in prostatic ca vs. 25% of BPH) downreg of PTEN
36
**What is the rate of permanent post-op urinary incontinence in dogs treated with total prostatectomy for prostatic carcinoma? (Bennett Vet Surg 2018)**
**35% (8/23)**
37
**What was prognostic for MST in dogs with prostatic carcinoma treated with total prostatectomy? What was the OST and 1/2yr survival? (Bennet Vet Surg 2018)**
**MST shorter for dogs with extracapsular tumor extension vs. intracapsular tumors** mOST = 231d (7.7mo), 1yr 32%, 2yr 12%
38
What was the rate of prostate adca being an incidental finding in dogs that were treated with IMRT? How did this impact MST? (Walz VCO 2019)
incidental in 40% MST longer if incidental - 581d (19.4mo) than if symptomatic 220d (7.3mo)
39
What was the rate of local LN mets in dogs treated with IMRT for prostatic carcinoma? Was this prognostic? (Walz, VCO 2019)
28% LN mets at dx 388d w/o mets (12.9mo) vs. 109d (3.6mo) w.
40
What was the rate of AEs for dogs with prostatic carcnoma treated with IMRT? What protocol was used? (Walz VCO 2019)
2.5-2.8gy/fx to total median 50Gy Acute AEs in 50% - mostly grade 1-2 diarrhea suspect late tox in 3/18 (17%) - urethral stricture, ureteral stricture, hindlimb edema
41
What was the mTTP and MST for dogs with prostatic carcinoma treated with IMRT? (Walze VCO 2019)
220d (7.3mo), MST 563d (18.8mo)
42
What IHC markers were expressed in most feline renal cell carcinomas? (Matsumoto Vet Path 2018)
CK7, CK20, Kit, CD10
43
**What IHC marker is helpful in distinguishing feline tumors arising from kidney vs. other neoplasms? (Ramos-Vara J Comp. Path 2017)**
**Pax8**
44
**What was the % of samples from renal FNA that were adequate for interpretation from dogs? What cancer type was this best for? (McAloney JAVMA 2018)**
72% adequate overall sensitivity 78% for neoplastic and 50% for nonneoplastic **sensitivity for LSA 100%**
45
For cats undergoing renal FNA\< what was the diagnostic yield what changes on AUS made it more likely that a diagnostic sample would be obtained? (McAloney JFMS 2017)
diagnostic yield 68% (48% moderately cellular) subcapsular renal infiltrate, diffuse renal enlargement w/o pelvic dilation and infiltrative/nodular change
46
**What gauge needle should be used for a renal core needle bx? (Crivellenti JAVMA 2018)**
**16ga - max dx quality of bx speciments from dogs with suspected kidney disease while avoiding apotential AEs caused by larger needles**
47
What Ki-67 proliferation found to be prognostic in canine renal cell carcinoma? (Suarez Bonnet Vet Path 2017)
Nope
48
**What were the IHC characteristics of canine renal cell carcinoma? (Gil da Costa Vet Path 2011)**
**All positive for uromodulin** **12/13 positive for c-kit** **11/13 positive for vimentin** **9/13 positive for cytokeratin**
49
75% of renal cell carcinoma in people is _____ type and \_\_\_\_\_% of these are associated with _____ mutation. This mutation (was/was not) found in dogs with renal neoplasia (Pressler JVIM 2009)
people: renal clear cell carcinoma, 85% hav VHL mutation NOT found in dogs
50
**What was the rate of bilateral renal tumors in dogs with renal neoplasia? (Bryan JVIM 2006)**
**4%**
51
**What were the most common clinical signs and hematologic abnormalities in dogs with renal neoplasia? (Bryan JVIM 2006)**
**CS: hematuria, inappetence, weight loss, lethargy, palp abd mass** **heme: neutrophilia, anemia, thrombocytopenia; 3 had polycythemia**
52
**What was the rate of mets at dx and at death for dogs with renal neoplasia (Bryan JVIM 2006Z)**
**16% pulm mets at dx** **77% at death**
53
**What was the MST associated with the different types of renal neoplasia in dogs? (Bryan JVIM 2006)**
**Carinoma 16mo** **Sarcoma 9mo** **nephroblastoma 6mo**
54
**What was the only independent prognostic factor found in canine renal cell carcinoma for dogs treated with nephrectomy? What other things were also prognostic (but not independent) (Edmondson Vet Path 2014)**
**Only independent: MI (\>30 MST 187d vs. \<10 1184 d. vs 10** **Poorer prognosis with clear cell, hematuria, cachexia**
55
What are Call-Exner bodies and what cancer are they associated with? (Masserdotti Vet Clin Path 2008)
Central round areas of amporphous, deeply eosinophilic hyaline material surrounded by a rosette-like arrangement of rows of Sertoli cells Sertoli cell tumors
56
What marker can be used to distinguish between the two types of seminoma in dogs? (Grieco J Comp Path 2010)
kit positive = classical seminoma negative = spermatocytic seminoma
57
**In a Norweigian study, what was the proportion of testicular tumors reported for canine cancer and what was the breakdown of the types/prevalence? (Nodtvedt VCO 2011)**
**2.4% of all cancer** **33% Leydig** **26.4% Sertoli** **33.9% seminoma/germ cell**
58
**What was the average age for dogs with testicular tumors? (Nodtvedt VCO 2011)**
**10yrs** **but lower for sertoli cell (8.6yrs)**
59
**Which dog breeds were more likely to have testicular tumors and what type of tumors were more common in these breeds? (Nodtvedt VCO 2011)**
**Shelties and Collies 5x more likely** **Sertoli cell tumors**
60
**In one study, all testticular tumors in Norwegian elkhounds were _____ (Nodtvedt VCO 2011)**
**Seminoma**
61
What was the ORR, mTTP and MST for dogs with bladder tumors treated with palladia? (Gustafson JAAHA 2019)
ORR: PR 6.7%, SD 80% mTTP 96d, MST post palladia: 150d
62
What % of dogs with bladder tumors had progression of azotemia while taking palladia? (Gustafson JAAHA 2019)
56%
63
**What is Tavocept and what is it used for? (Henry JVIM 2018)**
**Tavocept = chemoprotectant that has mitigated cisplat toxicity and decreased require infusion/diuresis time in poeple** **decreased in dogs as well - decreased from \>6hrs to 90min and decreased occurrence of azotemia w/o changing ST (but RR was inferior to control group)**
64
What was found in dogs with lower urinary tract carcinoma treated with IV vs. intraarterial carboplatin? (Culp JVIM 2015)
IA had greater decrease in longest diameter of tumor, more likely to have a response and less likely to develop anemia, anorexia or lethargy
65
What was the difference in response to mito + piroxicam or carbo + piroxicam for TCC in dogs? (Allstadt JVIM 2015)
No difference mito: PR 8%, SD 69% carbo PR 13%, SD 54% PFI also not sig different
66
**What was the effect of combining toc/vbl for treatement of canine TCC? How was response to treatment measured in these dogs? (Rippy BMC 2016)**
**combination didn't improve ORR (needed to decrease vbl to 1.6mg/m2 qwk, standard palladia)** **AUS vs. CT - agreement greater in CT**
67
**What was the ORR, MST and TTP for dogs with bladder cancer treated with 3mg/kg/day of deracoxib? (McMillan JAVMA 2011)**
**17% PR, 71% SD (13% PD)** **MST 323d (10.8mo), TTP 133d (4.4mo)** **Low tox - 4% (liver, kidney, GI)**
68
What is the response rate, mPFI and MST from first VBL for dogs with bladder cancer? (Arnold JVIM 2011)
3mg/m2 q2 36% PR, 50% SD mPFI 122d (4mo) MST from 1st vbl = 147d (5mo)
69
**What were imaging changes associated with prostatic LSA in dogs? (Donato VRU 2018)**
**78% = altered shape w/ rounded/irregular margins** **NO MINERALIZATION**
70
**Density of what tumor-infiltratig cells was shown to have a favorable prognosis in dogs with TCC? (Inoue Vet Immuno 2017)**
**CD3+ Granzyme B+ cells located in peritumoral stroma - independent prog indicator**
71
**What subtype of TVT may be more chemoresistant and why?**
**Plasmacytoid - greater expression of p-gp**
72
**What markers were expressed in canine TVT? (Stockmann VCO 2011)**
**92.3% expressed p53** **p63 and Bcl-2 also in most**
73
All TVT has a re-arrangement of what oncogene?
c-my re-arranged by insertion of a 1.5kbp transposable sequence known as the long interspersed element (LINE) 5 to the first exon